glutathione persister cells cancer Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse Redox signaling-governed drug-tolerant persister cancer
Redox signaling governed drug tolerant persister cancer cell: a key spark of treatment failure Signal Transduction and Targeted Therapy FSP1 and histone deacetylases suppress cancer persister cell ferroptosis Science Advances Redox signaling in drug tolerant persister cells as an emerging therapeutic target eBioMedicine Drug tolerant persister cancer cells are vulnerable to GPX4 inhibition Nature Frontiers Drug tolerant persister cells in cancer: a scoping review of definitions, models, and molecular mechanisms
Pay in 4 interest-free payments of $6.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




